ACCELERATING VACCINE DEVELOPMENT WITH MICROFLUIDIC CE WEBINAR

Accelerating Vaccine Development Using a Next Generation Microfluidic CE Platform

When producing a quality vaccine, all manufacturers must confirm the purity as well as the stability of their formulation and final product. Sample quantity and measurement time are often the throughput bottlenecks encountered during the process. As PerkinElmer’s LabChip® GXII Touch™ protein characterization system addresses these specific gaps, we’ve developed a literature-centric webinar. In this webinar you will learn:

  • The vaccine development and manufacturing process
  • The key applications of microfluidic CE in vaccine process development
Jeray Thelwell Biotherapeutics

Jeray Thelwell, a Mid-Atlantic and Southeast Biotherapeutics Solutions Specialist.  A researcher at heart, Jeray is an expert in assay development and automated liquid handling for genomic and biotherapeutic applications.

Recent Posts

Archives

Categories

Recent Tweets

For research use only. Not for use in diagnostic procedures.